| Literature DB >> 33356630 |
Yuna Kim1, Han Ah Lee2, Jae Seung Lee1, Mi Young Jeon1, Beom Kyung Kim1,3,4, Jun Yong Park1,3,4, Do Young Kim1,3,4, Sang Hoon Ahn1,3,4, Soon Ho Um2, Yeon Seok Seo2, Seung Up Kim1,3,4.
Abstract
Transarterial radioembolization (TARE) is one of the therapeutic options for hepatocellular carcinoma (HCC). This study aimed to investigate the predictors and prognostic values of achieving curative treatments after TARE. Overall, 143 patients with intrahepatic HCC treated with TARE between 2011 and 2017 were recruited from two Korean tertiary institutes. Twenty-seven patients received curative treatments after TARE. Younger age than 65 years and AFP of ≤200 ng/mL independently predicted the increased probability of achieving curative treatment after TARE, and the curative treatment after TARE provided a survival benefit in patients with intrahepatic HCC.Entities:
Keywords: TARE; Yttrium-90; curative treatment; hepatocellular carcinoma; radioembolization
Year: 2021 PMID： 33356630 DOI： 10.1080/07357907.2020.1870126
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176